课题基金 / 基金详情

A new therapeutic target in multiple sclerosis to attenuate neuroinflammation and neuropathology: the chondroitin sulfate proteoglycans

A new therapeutic target in multiple sclerosis to attenuate neuroinflammation and neuropathology: the chondroitin sulfate proteoglycans
减轻多发性硬化症神经炎症和神经病理学的新治疗靶点:硫酸软骨素蛋白聚糖
批准号:
343332
负责人:
Yong Voon W
金额:
$74.07万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2016
资助国家:
加拿大
项目状态:
已结题
起止时间:
2016-03-01 至 2021-03-01

项目摘要

项目成果

Yong Voon W的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Despite the introduction of several immune-modulating therapies in relapsing-remitting Multiple Sclerosis, treatment for many patients remains inadequate. There are also no treatments for patients with the progressive forms of Multiple Sclerosis. Thus,
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CSPG targeting for lesion regeneration in multiple sclerosis.
  • 批准号:
    415741
  • 项目类别:
    Operating Grants
  • 资助金额:
    $14.57万
  • 财政年份:
    2019
  • 负责人:
    Yong Voon W
  • 依托单位:
Alberta MS Network 2018 Scientific Forum
  • 批准号:
    383678
  • 项目类别:
    Miscellaneous Programs
  • 资助金额:
    $1.46万
  • 财政年份:
    2018
  • 负责人:
    Yong Voon W
  • 依托单位:
Harnessing neuroinflammation to develop new treatments for multiple sclerosis and glioblastoma
  • 批准号:
    388228
  • 项目类别:
    Operating Grants
  • 资助金额:
    $421.4万
  • 财政年份:
    2018
  • 负责人:
    Yong Voon W
  • 依托单位:
Mobilizing anti-tumor microglia/macrophages with niacin to improve the prognosis of glioblastoma: Bench to clinical trial and back.
  • 批准号:
    368380
  • 项目类别:
    Operating Grants
  • 资助金额:
    $90.56万
  • 财政年份:
    2017
  • 负责人:
    Yong Voon W
  • 依托单位:
海外基金